{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:01:20Z","timestamp":1792609280528,"version":"4.5.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11306-018-1398-9","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T13:32:26Z","timestamp":1533303146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma"],"prefix":"10.1007","volume":"14","author":[{"given":"A. W. L.","family":"Bayci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Somerset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Turkoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Hothem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. E.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bjorndahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bahado-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. F.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Keidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"1398_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s11306-013-0523-z","volume":"9","author":"T Abaffy","year":"2013","unstructured":"Abaffy, T., M\u00f6ller, M. G., Riemer, D. D., Milikowski, C., & DeFazio, R. A. (2013). Comparative analysis of volatile metabolomics signals from melanoma and benign skin: A pilot study. Metabolomics, 9, 998\u20131008.","journal-title":"Metabolomics"},{"key":"1398_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3945\/jn.108.103754","volume":"139","author":"SH Adams","year":"2009","unstructured":"Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., et al. (2009). Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. Journal of Nutrition, 139, 1073\u20131081.","journal-title":"Journal of Nutrition"},{"key":"1398_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/0148607186010002227","volume":"10","author":"B Adrian","year":"1986","unstructured":"Adrian, B. (1986). Arginine: Biochemistry, physiology, and therapeutic implications. Journal of Parenteral and Enteral Nutrition, 10, 227\u2013238.","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"key":"1398_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1586\/era.09.25","volume":"9","author":"SS Agarwala","year":"2009","unstructured":"Agarwala, S. S. (2009). Current systemic therapy for metastatic melanoma. Expert Review of Anticancer Therapy, 9, 587\u2013595.","journal-title":"Expert Review of Anticancer Therapy"},{"key":"1398_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4331\/wjbc.v6.i4.281","volume":"6","author":"E Ananieva","year":"2015","unstructured":"Ananieva, E. (2015). Targeting amino acid metabolism in cancer growth and anti-tumor immune response. World Journal of Biological Chemistry, 6, 281\u2013289.","journal-title":"World Journal of Biological Chemistry"},{"key":"1398_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.redox.2017.08.009","volume":"14","author":"L Andrisic","year":"2018","unstructured":"Andrisic, L., Dudzik, D., Barbas, C., Milkovic, L., Grune, T., & Zarkovic, N. (2018). Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer. Redox Biology, 14, 47\u201358.","journal-title":"Redox Biology"},{"key":"1398_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/nm.2438","volume":"17","author":"VP Balachandran","year":"2011","unstructured":"Balachandran, V. P., Cavnar, M. J., Zeng, S., Bamboat, Z. M., Ocuin, L. M., Obaid, H., et al. (2011). Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nature Medicine, 17, 1094.","journal-title":"Nature Medicine"},{"key":"1398_CR8","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch, C. M., Gershenwald, J. E., Soong, S. J., Thompson, J. F., Atkins, M. B., Byrd, D. R., et al. (2009). Final version of 2009 AJCC melanoma staging and classification. Jounal of Clinical Oncology, 27, 6199\u20136206.","journal-title":"Jounal of Clinical Oncology"},{"key":"1398_CR9","first-page":"6755","volume":"35","author":"V Barak","year":"2015","unstructured":"Barak, V., Leibovici, V., Peretz, T., Kalichman, I., Lotem, M., & Merims, S. (2015). Assessing response to new treatments and prognosis in melanoma patients, by the Biomarker S-100beta. Anticancer Research, 35, 6755\u20136760.","journal-title":"Anticancer Research"},{"key":"1398_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/15476910802131519","volume":"5","author":"AY Bedikian","year":"2008","unstructured":"Bedikian, A. Y., Johnson, M. M., Warneke, C. L., McIntyre, S., Papadopoulos, N., Hwu, W.-J., et al. (2008). Systemic therapy for unresectable metastatic melanoma: Impact of biochemotherapy on long-term survival. Journal of Immunotoxicology, 5, 201\u2013207.","journal-title":"Journal of Immunotoxicology"},{"key":"1398_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/metabo3030552","volume":"3","author":"RD Beger","year":"2013","unstructured":"Beger, R. D. (2013). A review of applications of metabolomics in cancer. Metabolites, 3, 552\u2013574.","journal-title":"Metabolites"},{"key":"1398_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1529-8019.2005.00049.x","volume":"18","author":"C Benvenuto-Andrade","year":"2005","unstructured":"Benvenuto-Andrade, C., Oseitutu, A., Agero, A. L., & Marghoob, A. A. (2005). Cutaneous melanoma: surveillance of patients for recurrence and new primary melanomas. Dermatologic Therapy, 18, 423\u2013435.","journal-title":"Dermatologic Therapy"},{"key":"1398_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1365-2230.2004.01623.x","volume":"29","author":"AK Bosserhoff","year":"2004","unstructured":"Bosserhoff, A. K., Kuster, H., & Hein, R. (2004). Elevated MIA levels in the serum of pregnant women and of children. Clinical and Experimental Dermatology: Clinical Dermatology, 29, 628\u2013629.","journal-title":"Clinical and Experimental Dermatology: Clinical Dermatology"},{"key":"1398_CR14","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1245\/s10434-010-1051-y","volume":"17","author":"TL Bowles","year":"2010","unstructured":"Bowles, T. L., Xing, Y., Hu, C.-Y., Mungovan, K. S., Askew, R. L., Chang, G. J., et al. (2010). Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Annals of Surgical Oncology, 17, 2015\u20132023.","journal-title":"Annals of Surgical Oncology"},{"key":"1398_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.bjc.6602321","volume":"92","author":"NG Burnet","year":"2005","unstructured":"Burnet, N. G., Jefferies, S. J., Benson, R. J., Hunt, D. P., & Treasure, F. P. (2005). Years of life lost (YLL) from cancer is an important measure of population burden\u2014And should be considered when allocating research funds. British Journal of Cancer, 92, 241\u2013245.","journal-title":"British Journal of Cancer"},{"key":"1398_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jaad.2004.08.034","volume":"52","author":"JA Carlson","year":"2005","unstructured":"Carlson, J. A., Ross, J. S., Slominski, A., Linette, G., Mysliborski, J., Hill, J., & Mihm, M. Jr. (2005). Molecular diagnostics in melanoma. Journal of the American Academy of Dermatology, 52, 743\u2013775.","journal-title":"Journal of the American Academy of Dermatology"},{"key":"1398_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1586\/14737159.3.2.163","volume":"3","author":"JA Carlson","year":"2003","unstructured":"Carlson, J. A., Slominski, A., Linette, G. P., Mihm, M. C. Jr., & Ross, J. S. (2003). Biomarkers in melanoma: predisposition, screening and diagnosis. Expert Review of Molecular Diagnostics, 3, 163\u2013184.","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"4","key":"1398_CR18","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., et al. (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New England Journal of Medicine, 364(4), 2507\u20132516.","journal-title":"New England Journal of Medicine"},{"key":"1398_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e328357d796","author":"KD Cromwell","year":"2012","unstructured":"Cromwell, K. D., Ross, M. I., Xing, Y., Gershenwald, J. E., Royal, R. E., Lucci, A., et al. (2012) Variability in melanoma post-treatment surveillance practices by country and physician specialty: A systematic review. Melanoma Research. https:\/\/doi.org\/10.1097\/CMR.0b013e328357d796 .","journal-title":"Melanoma Research"},{"issue":"1\u20134","key":"1398_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/DMDI.2000.17.1-4.109","volume":"17","author":"M Cuendet","year":"2000","unstructured":"Cuendet, M., & Pezzuto, M. (2000). The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabolism and Drug Interactions, 17(1\u20134), 109\u2013158.","journal-title":"Drug Metabolism and Drug Interactions"},{"key":"1398_CR21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bcp.2007.04.021","volume":"74","author":"BS Cummings","year":"2007","unstructured":"Cummings, B. S. (2007). Phospholipase A2 as targets for anti-cancer drugs. Biochemical Pharmacology, 74, 949\u2013959.","journal-title":"Biochemical Pharmacology"},{"key":"1398_CR22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3565(24)39138-4","volume":"294","author":"BS Cummings","year":"2000","unstructured":"Cummings, B.S., McHowat, J., & Schnellmann, R.G. (2000) Phospholipase A2s in cell injury and death. Journal of Pharmacology and Experimental Therapeutics, 294, 793\u2013799.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"1398_CR23","doi-asserted-by":"publisher","first-page":"e45190","DOI":"10.1371\/journal.pone.0045190","volume":"7","author":"J Ingeniis De","year":"2012","unstructured":"De Ingeniis, J., Richardson, R. B., Scott, A. D., Aza-Blanc, D. A., De, P. SK, et al (2012). Functional specialization in proline biosynthesis of melanoma. PLoS ONE, 7, e45190.","journal-title":"PLoS ONE"},{"key":"1398_CR24","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences 104, 19345\u201319350.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1398_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10434-999-0705-0","volume":"6","author":"LA DiFronzo","year":"1999","unstructured":"DiFronzo, L. A., Wanek, L. A., Elashoff, R., & Morton, D. L. (1999). Increased Incidence of Second Primary Melanoma in Patients With a Previous Cutaneous Melanoma. Annals of Surgical Oncology, 6, 705\u2013711.","journal-title":"Annals of Surgical Oncology"},{"key":"1398_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2005.08.012","volume":"240","author":"Q Dong","year":"2006","unstructured":"Dong, Q., Patel, M., Scott, K.F., Graham, G.G., Russell, P.J., & Sved, P. (2006) Oncogenic action of phospholipase A2 in prostate cancer. Cancer Letters 240, 9\u201316.","journal-title":"Cancer Letters"},{"key":"1398_CR27","unstructured":"Eidsmoe, K. (2018) Key statistics for melanoma skin cancer. American Cancer Society."},{"key":"1398_CR28","doi-asserted-by":"publisher","first-page":"15267","DOI":"10.1038\/ncomms15267","volume":"8","author":"I Elia","year":"2017","unstructured":"Elia, I., Broekaert, D., Christen, S., Boon, R., Radaelli, E., Orth, M. F., et al. (2017). Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nature Communications, 8, 15267.","journal-title":"Nature Communications"},{"key":"1398_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","volume-title":"Metabonomics: Methods and protocols","author":"A-H M Emwas","year":"2015","unstructured":"Emwas, A.-H. M. (2015). The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. In J. T. Bjerrum (Ed.), Metabonomics: Methods and protocols (pp.\u00a0161\u2013193). New York: Springer New York."},{"key":"1398_CR30","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.294.13.1647","volume":"294","author":"CR Ferrone","year":"2005","unstructured":"Ferrone, C. R., Ben Porat, L., Panageas, K. S., et al. (2005). Clinicopathological features of and risk factors for multiple primary melanomas. JAMA, 294, 1647\u20131654.","journal-title":"JAMA"},{"key":"1398_CR31","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2174\/138161208784246199","volume":"14","author":"L Feun","year":"2008","unstructured":"Feun, L., You, M., Wu, C. J., Kuo, M. T., Wangpaichitr, M., Spector, S., & Savaraj, N. (2008). Arginine deprivation as a targeted therapy for cancer. Current Pharmaceutical Design, 14, 1049\u20131057.","journal-title":"Current Pharmaceutical Design"},{"key":"1398_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., et al. (2012). Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma. New England Journal of Medicine, 367, 107\u2013114.","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"1398_CR33","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1158\/0008-5472.CAN-11-3105","volume":"72","author":"S Ganti","year":"2012","unstructured":"Ganti, S., Taylor, S. L., Abu Aboud, O., Yang, J., Evans, C., Osier, M. V., et al. (2012) Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Research, 72(14), 3471\u20133479","journal-title":"Cancer Research"},{"key":"1398_CR34","doi-asserted-by":"publisher","first-page":"18175","DOI":"10.1038\/srep18175","volume":"5","author":"R Gao","year":"2015","unstructured":"Gao, R., Cheng, J., Fan, C., Shi, X., Cao, Y., Sun, B., et al. (2015). Serum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinoma. Science Reports, 5, 18175.","journal-title":"Science Reports"},{"key":"1398_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/CMR.0b013e328042bb36","volume":"17","author":"C Garbe","year":"2007","unstructured":"Garbe, C., & Eigentler, T. K. (2007). Diagnosis and treatment of cutaneous melanoma: State of the art 2006. Melanoma Research, 17, 117\u2013127.","journal-title":"Melanoma Research"},{"key":"1398_CR36","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/elps.201400196","volume":"35","author":"R Gonzalez-Dominguez","year":"2014","unstructured":"Gonzalez-Dominguez, R., Garcia, A., Garcia-Barrera, T., Barbas, C., & Gomez-Ariza, J. L. (2014). Metabolomic profiling of serum in the progression of Alzheimer\u2019s disease by capillary electrophoresis-mass spectrometry. Electrophoresis, 35, 3321\u20133330.","journal-title":"Electrophoresis"},{"key":"1398_CR37","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1200\/JCO.2010.33.9275","volume":"29","author":"J Guo","year":"2011","unstructured":"Guo, J., Si, L., Kong, Y., Flaherty, K. T., Xu, X., Zhu, Y., et al. (2011). Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. Journal of Clinical Oncology, 29, 2904\u20132909.","journal-title":"Journal of Clinical Oncology"},{"key":"1398_CR38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2265.2011.04244.x","volume":"76","author":"CY Ha","year":"2012","unstructured":"Ha, C. Y., Kim, J. Y., Paik, J. K., Kim, O. Y., Paik, Y. H., Lee, E. J., & Lee, J. H. (2012). The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf), 76, 674\u2013682.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1398_CR39","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1007\/s11033-013-2691-3","volume":"40","author":"A Hasim","year":"2013","unstructured":"Hasim, A., Aili, A., Maimaiti, A., Mamtimin, B., Abudula, A., & Upur, H. (2013). Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection. Molecular Biology Reports, 40, 5853\u20135859.","journal-title":"Molecular Biology Reports"},{"key":"1398_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S., O\u2019Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., et al. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 363, 711\u2013723.","journal-title":"New England Journal of Medicine"},{"key":"1398_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/13556210020077028","volume":"6","author":"N Homann","year":"2001","unstructured":"Homann, N. (2001). Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production. Addiction Biology, 6, 309\u2013323.","journal-title":"Addiction Biology"},{"key":"1398_CR42","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-07-4144","volume":"14","author":"K Ino","year":"2008","unstructured":"Ino, K., Yamamoto, E., Shibata, K., Kajiyama, H., Yoshida, N., Terauchi, M., et al. (2008). Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: Its association with disease progression and survival. Clinical Cancer Research, 14, 2310\u20132317.","journal-title":"Clinical Cancer Research"},{"key":"1398_CR43","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","volume":"22","author":"F Izzo","year":"2004","unstructured":"Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., Rosa, V. D., et al. (2004). Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I\/II studies. Journal of Clinical Oncology, 22, 1815\u20131822.","journal-title":"Journal of Clinical Oncology"},{"key":"1398_CR44","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-2133.2009.09324.x","volume":"161","author":"L Jennings","year":"2009","unstructured":"Jennings, L., & Murphy, G. M. (2009). Predicting outcome in melanoma: Where are we now? British Journal of Dermatology, 161, 496\u2013503.","journal-title":"British Journal of Dermatology"},{"key":"1398_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/138920011796504536","volume":"12","author":"P Jolanta","year":"2011","unstructured":"Jolanta, P., Bozena, P.-S., Robert, B., Dorota, J., Piotr, N., Stanislaw, L., et al. (2011). L-Carnitine\u2014Metabolic functions and meaning in humans life. Current Drug Metabolism, 12, 667\u2013678.","journal-title":"Current Drug Metabolism"},{"key":"1398_CR46","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1158\/1055-9965.EPI-15-1223","volume":"25","author":"RS Kelly","year":"2016","unstructured":"Kelly, R. S., Vander Heiden, M. G., Giovannucci, E., & Mucci, L. A. (2016). Metabolomic biomarkers of prostate cancer: prediction, diagnosis, progression, prognosis, and recurrence. Cancer Epidemiology and Prevention Biomarkers, 25, 887\u2013906.","journal-title":"Cancer Epidemiology and Prevention Biomarkers"},{"key":"1398_CR47","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1158\/1078-0432.CCR-10-2402","volume":"17","author":"HM Kluger","year":"2011","unstructured":"Kluger, H. M., Hoyt, K., Bacchiocchi, A., Mayer, T., Kirsch, J., Kluger, Y., et al. (2011). Plasma markers for identifying patients with metastatic melanoma. Clinical Cancer Research, 17, 2417\u20132425.","journal-title":"Clinical Cancer Research"},{"key":"1398_CR118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.lungcan.2016.04.008","volume":"100","author":"A Klupczynska","year":"2016","unstructured":"Klupczynska, A., Derezi\u0144ski, P., Dyszkiewicz, W., Pawlak, K., Kasprzyk, M., & Kokot, Z. J. (2016). Evaluation of serum amino acid profiles\u2019 utility in non-small cell lung cancer detection in Polish population. Lung Cancer, 100, 71\u201376.","journal-title":"Lung Cancer"},{"key":"1398_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-09-0774","volume":"9","author":"E Kobayashi","year":"2010","unstructured":"Kobayashi, E., Masuda, M., Nakayama, R., Ichikawa, H., Satow, R., Shitashige, M., et al. (2010). Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma. Molecular Cancer Therapeutics, 9, 535\u2013544.","journal-title":"Molecular Cancer Therapeutics"},{"key":"1398_CR117","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/1055-9965.EPI-12-1033","volume":"22","author":"T Kobayashi","year":"2013","unstructured":"Kobayashi, T., Nishiumi, S., Ikeda, A., Yoshie, T., Sakai, A., Matsubara, A., et al. (2013). A novel serum metabolomics-based diagnostic approach to pancreatic cancer. Cancer Epidemiology Biomarkers & Prevention 22, 571\u2013579.","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"1398_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-016-0552-3","volume":"14","author":"T Kuhn","year":"2016","unstructured":"Kuhn, T., Floegel, A., Sookthai, D., Johnson, T., Rolle-Kampczyk, U., Otto, W., et al. (2016). Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Medicine, 14, 13.","journal-title":"BMC Medicine"},{"key":"1398_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1753-4887.1990.tb02967.x","volume":"48","author":"JM Lacey","year":"1990","unstructured":"Lacey, J. M., & Wilmore, D. W. (1990). Is glutamine a conditionally essential amino acid? Nutrition Reviews, 48, 297\u2013309.","journal-title":"Nutrition Reviews"},{"key":"1398_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ncponc1296","volume":"6","author":"AR Larson","year":"2009","unstructured":"Larson, A. R., Konat, E., & Alani, R. M. (2009). Melanoma biomarkers: Current status and vision for the future. Nature Clinical Practice Oncology, 6, 105\u2013117.","journal-title":"Nature Clinical Practice Oncology"},{"key":"1398_CR52","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S1359-6446(03)02754-5","volume":"8","author":"JP Laye","year":"2003","unstructured":"Laye, J. P., & Gill, J. H. (2003). Phospholipase A2 expression in tumours: A target for therapeutic intervention? Drug Discovery Today, 8, 710\u2013716.","journal-title":"Drug Discovery Today"},{"key":"1398_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/978-2-88945-041-1","volume-title":"Biomarkers of Alzheimer\u2019s disease: The present and the future","author":"S Lehman","year":"2016","unstructured":"Lehman, S., & Teunissen, C. E. (2016). Biomarkers of Alzheimer\u2019s disease: The present and the future. Lausanne: Frontiers Media SA."},{"key":"1398_CR54","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/ijc.21262","volume":"117","author":"F Levi","year":"2005","unstructured":"Levi, F., Randimbison, L., Te, V.-C., & La Vecchia, C. (2005). High constant incidence rates of second cutaneous melanomas. International Journal of Cancer, 117, 877\u2013879.","journal-title":"International Journal of Cancer"},{"key":"1398_CR55","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1158\/1055-9965.EPI-13-0584","volume":"22","author":"DB Liesenfeld","year":"2013","unstructured":"Liesenfeld, D. B., Habermann, N., Owen, R. W., Scalbert, A., & Ulrich, C. M. (2013a). Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiology, Biomarkers & Prevention, 22, 2182\u20132201.","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"1398_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00109-016-1452-x","volume":"95","author":"X Lin","year":"2017","unstructured":"Lin, X., Sun, R., Zhao, X., Zhu, D., Zhao, X., Gu, Q., Dong, X., et al. (2017). C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc\/snail\/Bax signaling. Journal of Molecular Medicine, 95, 53\u201367.","journal-title":"Journal of Molecular Medicine"},{"key":"1398_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1129-2377-14-55","volume":"14","author":"L Lionetto","year":"2013","unstructured":"Lionetto, L., Gentile, G., Bellei, E., Capi, M., Sabato, D., Marsibilio, F., et al. (2013). The omics in migraine. Journal of Headache and Pain, 14, 55.","journal-title":"Journal of Headache and Pain"},{"key":"1398_CR58","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1073\/pnas.1203244109","volume":"109","author":"W Liu","year":"2012","unstructured":"Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W. M., et al. (2012). Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proceedings of the National Academy of Sciences of the United States of America, 109, 8983\u20138988.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1398_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.pcan.4500879","volume":"9","author":"Y Liu","year":"2006","unstructured":"Liu, Y. (2006). Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer And Prostatic Diseases, 9, 230.","journal-title":"Prostate Cancer And Prostatic Diseases"},{"key":"1398_CR60","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.3748\/wjg.v20.i26.8653","volume":"20","author":"H Ma","year":"2014","unstructured":"Ma, H., Hasim, A., Mamtimin, B., Kong, B., Zhang, H.-P., & Sheyhidin, I. (2014). Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy. World Journal of Gastroenterology: WJG, 20, 8653\u20138659.","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"1398_CR61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"F Meier","year":"2002","unstructured":"Meier, F., Will, S., Ellwanger, U., Schlagenhauff, B., Schittek, B., Rassner, G., & Garbe, C. (2002). Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. British Journal of Dermatology, 147, 62\u201370.","journal-title":"British Journal of Dermatology"},{"key":"1398_CR62","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","volume":"20","author":"AL Mellor","year":"1999","unstructured":"Mellor, A. L., & Munn, D. H. (1999). Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunology Today, 20, 469\u2013473.","journal-title":"Immunology Today"},{"key":"1398_CR63","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/carcin\/bgh150","volume":"25","author":"AM Meyer","year":"2004","unstructured":"Meyer, A. M., Dwyer-Nield, L. D., Hurteau, G. J., Keith, R. L., O\u2019Leary, E., You, M., et al. (2004). Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A 2. Carcinogenesis, 25, 1517\u20131524.","journal-title":"Carcinogenesis"},{"key":"1398_CR64","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/oby.2009.510","volume":"18","author":"SJ Mihalik","year":"2010","unstructured":"Mihalik, S. J., Goodpaster, B. H., Kelley, D. E., Chace, D. H., Vockley, J., Toledo, F. G., et al. (2010). Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring), 18, 1695\u20131700.","journal-title":"Obesity (Silver Spring)"},{"key":"1398_CR65","doi-asserted-by":"publisher","first-page":"e24143","DOI":"10.1371\/journal.pone.0024143","volume":"6","author":"Y Miyagi","year":"2011","unstructured":"Miyagi, Y., Higashiyama, M., Gochi, A., Akaike, M., Ishikawa, T., Miura, T., et al. (2011). Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS ONE, 6, e24143.","journal-title":"PLoS ONE"},{"key":"1398_CR66","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.suc.2014.07.003","volume":"94","author":"AA Mrazek","year":"2014","unstructured":"Mrazek, A. A., & Chao, C. (2014). Surviving Cutaneous melanoma: A clinical review of follow-up practices, surveillance, and management of recurrence. The Surgical clinics of North America, 94, 989\u20131002.","journal-title":"The Surgical clinics of North America"},{"key":"1398_CR67","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11306-010-0250-7","volume":"7","author":"DJY Ng","year":"2011","unstructured":"Ng, D. J. Y., Pasikanti, K. K., & Chan, E. C. Y. (2011). Trend analysis of metabonomics and systematic review of metabonomics-derived cancer marker metabolites. Metabolomics, 7, 155\u2013178.","journal-title":"Metabolomics"},{"key":"1398_CR68","unstructured":"NIH (2017) Cancer stat facts: Melanoma. National Cancer Institute: Surveillance, Epidemiology & End Results (SEER) Program."},{"key":"1398_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","volume":"140","author":"DK Nomura","year":"2010","unstructured":"Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010). Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell, 140, 49\u201361.","journal-title":"Cell"},{"key":"1398_CR70","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1158\/1078-0432.CCR-04-2671","volume":"11","author":"A Okamoto","year":"2005","unstructured":"Okamoto, A., Nikaido, T., Ochiai, K., Takakura, S., Saito, M., Aoki, Y., et al. (2005). Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Clinical Cancer Research, 11, 6030\u20136039.","journal-title":"Clinical Cancer Research"},{"key":"1398_CR71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., et al. (2011). An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature, 478, 197.","journal-title":"Nature"},{"key":"1398_CR72","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1158\/1078-0432.CCR-13-0143","volume":"19","author":"PA Ott","year":"2013","unstructured":"Ott, P. A., Hodi, F. S., & Robert, C. (2013). CTLA-4 and PD-1\/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients. Clinical Cancer Research, 19, 5300\u20135309.","journal-title":"Clinical Cancer Research"},{"key":"1398_CR73","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40170-016-0145-9","volume":"4","author":"AM Otto","year":"2016","unstructured":"Otto, A. M. (2016). Warburg effect(s)\u2014A biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer & Metabolism, 4, 5.","journal-title":"Cancer & Metabolism"},{"key":"1398_CR74","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/nnm.14.101","volume":"10","author":"D Pan","year":"2015","unstructured":"Pan, D., Kim, B., Hu, G., Gupta, D. S., Senpan, A., Yang, X., et al. (2015). A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy. Nanomedicine (London, England), 10, 241\u2013251.","journal-title":"Nanomedicine (London, England)"},{"key":"1398_CR75","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00726-008-0063-4","volume":"35","author":"JM Phang","year":"2008","unstructured":"Phang, J. M., Donald, S. P., Pandhare, J., & Liu, Y. (2008). The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids, 35, 681\u2013690.","journal-title":"Amino Acids"},{"key":"1398_CR76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MCO.0000000000000121","volume":"18","author":"JM Phang","year":"2015","unstructured":"Phang, J. M., Liu, W., Hancock, C. N., & Fischer, J. W. (2015). Proline metabolism and cancer: emerging links to glutamine and collagen. Current Opinion in Clinical Nutrition and Metabolic Care, 18, 71\u201377.","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"1398_CR77","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1073\/pnas.1113873109","volume":"109","author":"L Pilotte","year":"2012","unstructured":"Pilotte, L., Larrieu, P., Stroobant, V., Colau, D., Dolu\u0161i\u0107, E., Fr\u00e9d\u00e9rick, R., et al. (2012). Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proceedings of the National Academy of Sciences of the United States of America, 109, 2497\u20132502.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1398_CR78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/alcalc\/agh057","volume":"39","author":"G Poschl","year":"2004","unstructured":"Poschl, G., & Seitz, H. K. (2004). Alcohol and cancer. Alcohol Alcohol, 39, 155\u2013165.","journal-title":"Alcohol Alcohol"},{"key":"1398_CR79","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/478192a","volume":"478","author":"GC Prendergast","year":"2011","unstructured":"Prendergast, G. C. (2011). Why tumours eat tryptophan. Nature, 478, 192.","journal-title":"Nature"},{"key":"1398_CR80","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/138161210790232121","volume":"16","author":"M Qingyong","year":"2010","unstructured":"Qingyong, M., Zheng, W., Min, Z., Hengtong, H., Junhui, L., Dong, Z., et al. (2010). Targeting the L-arginine-nitric oxide pathway for cancer treatment. Current Pharmaceutical Design, 16, 392\u2013410.","journal-title":"Current Pharmaceutical Design"},{"key":"1398_CR81","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-13-1939","volume":"20","author":"Y Qiu","year":"2014","unstructured":"Qiu, Y., Cai, G., Zhou, B., Li, D., Zhao, A., Xie, G., et al. (2014). A distinct metabolic signature of human colorectal cancer with prognostic potential. Clin Cancer Research, 20, 2136\u20132146.","journal-title":"Clin Cancer Research"},{"key":"1398_CR82","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.3390\/ijms14048047","volume":"14","author":"Y Qiu","year":"2013","unstructured":"Qiu, Y., Zhou, B., Su, M., Baxter, S., Zheng, X., Zhao, X., Yen, Y., & Jia, W. (2013). Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. International Journal of Molecular Sciences, 14, 8047\u20138061.","journal-title":"International Journal of Molecular Sciences"},{"key":"1398_CR83","doi-asserted-by":"publisher","first-page":"e0124219","DOI":"10.1371\/journal.pone.0124219","volume":"10","author":"S Ravanbakhsh","year":"2015","unstructured":"Ravanbakhsh, S., Liu, P., Bjordahl, T. C., Mandal, R., Grant, J. R., Wilson, M., et al. (2015). Accurate, fully-automated NMR spectral profiling for metabolomics. PLoS ONE, 10, e0124219.","journal-title":"PLoS ONE"},{"key":"1398_CR84","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/10409238.2012.735643","volume":"48","author":"ND Ridgway","year":"2013","unstructured":"Ridgway, N. D. (2013). The role of phosphatidylcholine and choline metabolites to cell proliferation and survival. Critical Reviews in Biochemistry and Molecular Biology, 48, 20\u201338.","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"key":"1398_CR85","unstructured":"Rim, J. H., Choi, J. R., & Lee, S.-G. (2012) Metabolomic profile change in type 2 diabetes revealed by commercial metabolomics kit with mass spectrometry, Mass Spectrometry: Applications to the Clinical Lab (MSACL) 2016 US."},{"key":"1398_CR86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., et al. (2015). Improved overall survival in melanoma with combined dabrafenib and trametinib. New England Journal of Medicine, 372, 30\u201339.","journal-title":"New England Journal of Medicine"},{"key":"1398_CR87","doi-asserted-by":"publisher","first-page":"843214","DOI":"10.1155\/2014\/843214","volume":"2014","author":"A Sandru","year":"2014","unstructured":"Sandru, A., Panaitescu, E., Voinea, S., Bolovan, M., Stanciu, A., Cinca, S., & Blidaru, A. (2014) Prognostic value of melanoma inhibitory activity protein in localized cutaneous malignant melanoma. Journal of Skin Cancer 2014, 843214.","journal-title":"Journal of Skin Cancer"},{"key":"1398_CR88","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ejca.2010.04.027","volume":"46","author":"T Sasahira","year":"2010","unstructured":"Sasahira, T., Kirita, T., Kurihara, M., Yamamoto, K., Bhawal, U. K., Bosserhoff, A. K., et al. (2010). MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma. European Journal of Cancer, 46, 2285\u20132294.","journal-title":"European Journal of Cancer"},{"key":"1398_CR89","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1046\/j.1365-2133.2001.04507.x","volume":"145","author":"MH Schmid-Wendtner","year":"2001","unstructured":"Schmid-Wendtner, M. H., Baumert, J., Wendtner, C. M., Plewig, G., & Volkenandt, M. (2001). Risk of second primary malignancies in patients with cutaneous melanoma. British Journal of Dermatology, 145, 981\u2013985.","journal-title":"British Journal of Dermatology"},{"key":"1398_CR90","doi-asserted-by":"publisher","first-page":"137S","DOI":"10.1111\/j.1530-0277.2001.tb02388.x","volume":"25","author":"HK Seitz","year":"2001","unstructured":"Seitz, H. K., Matsuzaki, S., Yokoyama, A., Homann, N., Vakevainen, S., & Wang, X. D. (2001). Alcohol and cancer. Alcoholism: Clinical and Experimental Research, 25, 137S\u2013143S.","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"1398_CR91","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","volume":"163","author":"SH Shah","year":"2012","unstructured":"Shah, S. H., Sun, J. L., Stevens, R. D., Bain, J. R., Muehlbauer, M. J., Pieper, K. S., et al. (2012). Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. American Heart Journal, 163, 844\u2013850 e1.","journal-title":"American Heart Journal"},{"key":"1398_CR92","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00726-016-2215-2","volume":"48","author":"E Simi\u0144ska","year":"2016","unstructured":"Simi\u0144ska, E., & Koba, M. (2016). Amino acid profiling as a method of discovering biomarkers for early diagnosis of cancer. Amino Acids, 48, 1339\u20131345.","journal-title":"Amino Acids"},{"key":"1398_CR93","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A","volume":"67","author":"S-J Soong","year":"1998","unstructured":"Soong, S.-J., Harrison, R. A., McCarthy, W. H., Urist, M. M., & Balch, C. M. (1998). Factors affecting survival following local, regional, or distant recurrence from localized melanoma. Journal of Surgical Oncology, 67, 228\u2013233.","journal-title":"Journal of Surgical Oncology"},{"key":"1398_CR94","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","volume":"12","author":"V Sosa","year":"2013","unstructured":"Sosa, V., Molin\u00e9, T., Somoza, R., Paciucci, R., Kondoh, H., & LLeonart, M. E. (2013). Oxidative stress and cancer: An overview. Ageing Research Reviews, 12, 376\u2013390.","journal-title":"Ageing Research Reviews"},{"key":"1398_CR95","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.1073\/pnas.1416560111","volume":"111","author":"PW Szlosarek","year":"2014","unstructured":"Szlosarek, P. W. (2014) Arginine deprivation and autophagic cell death in cancer. Proceedings of the National Academy of Sciences 111, 14015\u201314016.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1398_CR96","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc2817","volume":"10","author":"DA Tennant","year":"2010","unstructured":"Tennant, D. A., Dur\u00e1n, R. V., & Gottlieb, E. (2010). Targeting metabolic transformation for cancer therapy. Nature Reviews Cancer, 10, 267.","journal-title":"Nature Reviews Cancer"},{"key":"1398_CR97","first-page":"18","volume":"6","author":"SC Trotter","year":"2013","unstructured":"Trotter, S. C., Sroa, N., Winkelmann, R. R., Olencki, T., & Bechtel, M. (2013). A global review of melanoma follow-up guidelines. The Journal of Clinical and Aesthetic Dermatology, 6, 18\u201326.","journal-title":"The Journal of Clinical and Aesthetic Dermatology"},{"key":"1398_CR98","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove, C., Pilotte, L., Th\u00e9ate, I., Stroobant, V., Colau, D., Parmentier, N., et al. (2003). Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nature Medicine, 9, 1269.","journal-title":"Nature Medicine"},{"key":"1398_CR99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/healthcare2010060","volume":"2","author":"S Verykiou","year":"2014","unstructured":"Verykiou, S., Ellis, R. A., & Lovat, P. E. (2014). Established and emerging biomarkers in cutaneous malignant melanoma. Healthcare (Basel), 2, 60\u201373.","journal-title":"Healthcare (Basel)"},{"key":"1398_CR100","first-page":"229","volume":"6","author":"RK Voss","year":"2015","unstructured":"Voss, R. K., Woods, T. N., Cromwell, K. D., Nelson, K. C., & Cormier, J. N. (2015). Improving outcomes in patients with melanoma: Strategies to ensure an early diagnosis. Patient Related Outcome Measures, 6, 229\u2013242.","journal-title":"Patient Related Outcome Measures"},{"key":"1398_CR101","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ijc.28749","volume":"135","author":"Q Wang","year":"2014","unstructured":"Wang, Q., Beaumont, K. A., Otte, N. J., Font, J., Bailey, C. G., van Geldermalsen, M., et al. (2014). Targeting glutamine transport to suppress melanoma cell growth. International Journal of Cancer, 135, 1060\u20131071.","journal-title":"International Journal of Cancer"},{"key":"1398_CR102","first-page":"13","volume":"7","author":"D Weinstein","year":"2014","unstructured":"Weinstein, D., Leininger, J., Hamby, C., & Safai, B. (2014). Diagnostic and Prognostic Biomarkers in Melanoma. The Journal of Clinical and Aesthetic Dermatology, 7, 13\u201324.","journal-title":"The Journal of Clinical and Aesthetic Dermatology"},{"key":"1398_CR103","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1073\/pnas.0810199105","volume":"105","author":"DR Wise","year":"2008","unstructured":"Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., et al. (2008). Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America, 105, 18782\u201318787.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1398_CR104","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-1-60327-194-3_14","volume":"593","author":"DS Wishart","year":"2010","unstructured":"Wishart, D. S. (2010). Computational approaches to metabolomics. Methods in Molecular Biology, 593, 283\u2013313.","journal-title":"Methods in Molecular Biology"},{"key":"1398_CR105","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.4155\/bio.11.155","volume":"3","author":"DS Wishart","year":"2011","unstructured":"Wishart, D. S. (2011). Advances in metabolite identification. Bioanalysis, 3, 1769\u20131782.","journal-title":"Bioanalysis"},{"key":"1398_CR106","doi-asserted-by":"publisher","first-page":"D603","DOI":"10.1093\/nar\/gkn810","volume":"37","author":"DS Wishart","year":"2009","unstructured":"Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: A knowledgebase for the human metabolome. Nucleic Acids Research, 37, D603\u2013D610.","journal-title":"Nucleic Acids Research"},{"key":"1398_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2008.05.001","volume":"395","author":"J Wojciech","year":"2008","unstructured":"Wojciech, J., & Szmitkowski, M. (2008). Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clinica Chimica Acta, 395, 1\u20135.","journal-title":"Clinica Chimica Acta"},{"key":"1398_CR108","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","volume":"9","author":"J Xia","year":"2013","unstructured":"Xia, J., Broadhurst, D. I., Wilson, M., & Wishart, D. S. (2013). Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics, 9, 280\u2013299.","journal-title":"Metabolomics"},{"key":"1398_CR109","doi-asserted-by":"publisher","first-page":"W127","DOI":"10.1093\/nar\/gks374","volume":"40","author":"J Xia","year":"2012","unstructured":"Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D., & Wishart, D. S. (2012). MetaboAnalyst 2.0\u2013a comprehensive server for metabolomic data analysis. Nucleic Acids Research, 40, W127\u2013W133.","journal-title":"Nucleic Acids Research"},{"key":"1398_CR110","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia, J., Psychogios, N., Young, N., & Wishart, D. S. (2009). MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Research, 37, W652\u2013W660.","journal-title":"Nucleic Acids Research"},{"key":"1398_CR111","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia, J., Sinelnikov, I. V., Han, B., & Wishart, D. S. (2015). MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Research, 43, W251\u2013W257.","journal-title":"Nucleic Acids Research"},{"key":"1398_CR112","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/cncr.24966","volume":"116","author":"Y Xing","year":"2010","unstructured":"Xing, Y., Chang, G. J., Hu, C.-Y., Askew, R. L., Ross, M. I., Gershenwald, J. E., et al. (2010). Conditional survival estimates improve over time for patients with advanced melanoma. Cancer, 116, 2234\u20132241.","journal-title":"Cancer"},{"key":"1398_CR113","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4331\/wjbc.v3.i8.167","volume":"3","author":"F Zhang","year":"2012","unstructured":"Zhang, F., & Du, G. (2012). Dysregulated lipid metabolism in cancer. World Journal of Biological Chemistry, 3, 167\u2013174.","journal-title":"World Journal of Biological Chemistry"},{"key":"1398_CR116","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1158\/1055-9965.EPI-10-0126","volume":"19","author":"M Zhou","year":"2010","unstructured":"Zhou, M., Guan, W., Walker, L .D., Mezencev, R., Benigno, B. B., Gray, A., et al. (2010). Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy. Cancer Epidemiology Biomarkers & Prevention, 19, 2262\u20132271.","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"1398_CR114","doi-asserted-by":"publisher","first-page":"e48889","DOI":"10.1371\/journal.pone.0048889","volume":"7","author":"X Zhou","year":"2012","unstructured":"Zhou, X., Mao, J., Ai, J., Deng, Y., Roth, M. R., Pound, C., Henegar, J., Welti, R., & Bigler, S. A. (2012). Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS ONE, 7, e48889.","journal-title":"PLoS ONE"},{"key":"1398_CR115","doi-asserted-by":"publisher","first-page":"e0124844","DOI":"10.1371\/journal.pone.0124844","volume":"10","author":"BN Zordoky","year":"2015","unstructured":"Zordoky, B. N., Sung, M. M., Ezekowitz, J., Mandal, R., Han, B., Bjorndahl, T. C., Bouatra, S., Anderson, T., Oudit, G. Y., Wishart, D. S., Dyck, J. R., & Alberta, H. (2015). Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS ONE, 10, e0124844.","journal-title":"PLoS ONE"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11306-018-1398-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-018-1398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-018-1398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T05:58:32Z","timestamp":1751781512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11306-018-1398-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1007\/s11306-018-1398-9","relation":{},"ISSN":["1573-3882","1573-3890"],"issn-type":[{"value":"1573-3882","type":"print"},{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board (IRB) at William Beaumont Hospital in Royal Oak, Michigan. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"105"}}